Overview Experience People Events Intelligence Stem Cell Technologies 12next A Patent Landscape Analysis: iPSCs 17 May 2013 Personalized Medicine Bulletin There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape analysis focusing... U.S. Supreme Court Asked to Review Federal Funding of Human Embryonic Stem Cell Research 18 October 2012 Personalized Medicine Bulletin On October 10, 2012, two pro-life groups petitioned the U.S. Supreme Court to review and reverse the U.S. Court of Appeals for the District of Columbia Circuit Court’s... Federal Stem Cell Funding Approved by Appellate Court 28 August 2012 Personalized Medicine Bulletin Good news for patients and stem cell researchers alike. On August 24th, the United States Courts of Appeals for the District of Columbia Circuit affirmed the District... Stem Cell Funding Stay Vacated—Uncertainty Remains 03 May 2011 Legal News Alert: Life Sciences On April 29, 2011, the United States Court of Appeals for the District of Columbia Circuit vacated the preliminary injunction in Sherley v. Sibelius, No. 10-5287,... Federal Circuit Reaffirms Patent Eligibility of Personalized Medicine and Diagnostic Method Claims 17 December 2010 Legal News Alert: Chemical, Biotechnology & Pharmaceutical Today, in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. 2010), the Federal Circuit affirmed that personalized medicine and... Stem Cell Funding Controversy Creates Uncertainty for Ongoing and Future Research 01 December 2010 AHLA Connections Antoinette Konski and George Best authored an article that appeared in the December 2010 issue of AHLA Connections titled "Stem Cell Funding Controversy Creates... An Unclear Future for Stem Cell Research: District Court Orders Federal Government to Halt Embryonic Stem Cell Research Funding 24 August 2010 Legal News Alert: Life Sciences On August 23, 2010, Chief Judge Royce C. Lamberth of U.S. District Court for the District of Columbia granted a preliminary injunction in a lawsuit challenging the... Personalized Medicine: Innovation, Threats and Opportunities 14 July 2010 Bloomberg's Intellectual Property Law Report Foley Partners Antoinette Konski and Judith Waltz authored an article that appeared in the July 2010 issue of Bloomberg's Intellectual Property Law Report titled... Patent Eligibility May Not Be Settled for Diagnostic and Personalized Medicine Method Claims 29 June 2010 Legal News Alert: Life Sciences On the heels of its decision in Bilski v. Kappos, the Supreme Court resolved the pending petition seeking review of the Federal Circuit’s decision in Prometheus... Health Care Reform — What's in It for Life Sciences Companies? 12 April 2010 Legal News Alert: Life Sciences On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act (the Act). This Legal News Alert provides a brief outline of different provisions... 12next Related 1 2 3
A Patent Landscape Analysis: iPSCs 17 May 2013 Personalized Medicine Bulletin There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape analysis focusing...
U.S. Supreme Court Asked to Review Federal Funding of Human Embryonic Stem Cell Research 18 October 2012 Personalized Medicine Bulletin On October 10, 2012, two pro-life groups petitioned the U.S. Supreme Court to review and reverse the U.S. Court of Appeals for the District of Columbia Circuit Court’s...
Federal Stem Cell Funding Approved by Appellate Court 28 August 2012 Personalized Medicine Bulletin Good news for patients and stem cell researchers alike. On August 24th, the United States Courts of Appeals for the District of Columbia Circuit affirmed the District...
Stem Cell Funding Stay Vacated—Uncertainty Remains 03 May 2011 Legal News Alert: Life Sciences On April 29, 2011, the United States Court of Appeals for the District of Columbia Circuit vacated the preliminary injunction in Sherley v. Sibelius, No. 10-5287,...
Federal Circuit Reaffirms Patent Eligibility of Personalized Medicine and Diagnostic Method Claims 17 December 2010 Legal News Alert: Chemical, Biotechnology & Pharmaceutical Today, in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. 2010), the Federal Circuit affirmed that personalized medicine and...
Stem Cell Funding Controversy Creates Uncertainty for Ongoing and Future Research 01 December 2010 AHLA Connections Antoinette Konski and George Best authored an article that appeared in the December 2010 issue of AHLA Connections titled "Stem Cell Funding Controversy Creates...
An Unclear Future for Stem Cell Research: District Court Orders Federal Government to Halt Embryonic Stem Cell Research Funding 24 August 2010 Legal News Alert: Life Sciences On August 23, 2010, Chief Judge Royce C. Lamberth of U.S. District Court for the District of Columbia granted a preliminary injunction in a lawsuit challenging the...
Personalized Medicine: Innovation, Threats and Opportunities 14 July 2010 Bloomberg's Intellectual Property Law Report Foley Partners Antoinette Konski and Judith Waltz authored an article that appeared in the July 2010 issue of Bloomberg's Intellectual Property Law Report titled...
Patent Eligibility May Not Be Settled for Diagnostic and Personalized Medicine Method Claims 29 June 2010 Legal News Alert: Life Sciences On the heels of its decision in Bilski v. Kappos, the Supreme Court resolved the pending petition seeking review of the Federal Circuit’s decision in Prometheus...
Health Care Reform — What's in It for Life Sciences Companies? 12 April 2010 Legal News Alert: Life Sciences On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act (the Act). This Legal News Alert provides a brief outline of different provisions...